Top Story

NEI grants $1 million to re-create ocular stem cells

November 25, 2014

The National Eye Institute has granted researchers at the Icahn School of Medicine at Mount Sinai a 5-year $1 million grant supporting discovery of new stem cell therapies for ocular surface disease, according to a Mount Sinai press release.

The grant will support the investigation of viable stem cell sources, the re-creation of ocular stem cells from eyelid or oral skin cells, molecular pathways of ocular and orbital development and biomaterials to restore vision, according to the press release.

Meeting News Coverage

Alcon marks support of CLAY studies

November 24, 2014
DENVER – Alcon noted its 5 years of support for the Contact Lens Assessment in Youth team during a company-sponsored press conference here at the American Academy of…

Ocular Therapeutix reports third-quarter net loss of $7.3 million

November 24, 2014
Ocular Therapeutix reported a third-quarter net loss of approximately $7.3 million, or $0.48 per share, compared with a net loss of $3.5 million, or $1.34 per share, in…

Apellis to acquire Potentia Pharmaceuticals

November 21, 2014
Apellis Pharmaceuticals has entered into an agreement to acquire Potentia Pharmaceuticals, according to a press release.Through the agreement, Apellis obtained the…
CME
Postoperative Inflammation and Pain

Postoperative Inflammation and Pain: Elimination of the Dynamic Duo to Improve Patient Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Cataract surgery has improved in both safety and outcomes in recent years. With advances in surgical techniques…
More »
Video
John Hovanesian th

Omeros granted CMS pass-through reimbursement status for Omidria

October 31, 2014
The Center for Medicare and Medicaid Services has granted Omeros Corporation with transitional pass-through status for…
More »

NEI grants $1 million to re-create ocular stem cells

November 25, 2014
The National Eye Institute has granted researchers at the Icahn School of Medicine at Mount Sinai a 5-year $1 million grant supporting discovery of…
Meeting News Coverage

Alcon marks support of CLAY studies

November 24, 2014
DENVER – Alcon noted its 5 years of support for the Contact Lens Assessment in Youth team during a company-sponsored press conference here at the…

Ocular Therapeutix reports third-quarter net loss of $7.3 million

November 24, 2014
Ocular Therapeutix reported a third-quarter net loss of approximately $7.3 million, or $0.48 per share, compared with a net loss of $3.5 million, or…

Apellis to acquire Potentia Pharmaceuticals

November 21, 2014
Apellis Pharmaceuticals has entered into an agreement to acquire Potentia Pharmaceuticals, according to a press release.Through the agreement…

Imprimis reports $2.5 million net loss in third quarter

November 21, 2014
Imprimis Pharmaceuticals reported a net loss of $2.5 million, or $0.27 per common share, in the third quarter, compared with a loss of $2.1 million…

Ocular Therapeutix to evaluate sustained-release travoprost for glaucoma, ocular hypertension

November 21, 2014
Ocular Therapeutix has begun enrolling the first subjects in a phase 2b clinical trial to evaluate the safety and efficacy of sustained-release…

Valeant announces $2 billion Securities Repurchase Program

November 20, 2014
A new securities repurchase program that will allow Valeant Pharmaceuticals to make purchases up to $2 billion of its senior notes, common shares and…

Optos reports 7% increase in third-quarter revenue

November 20, 2014
Optos totaled $170.6 million in revenue and operating income in the third quarter, a 7% increase from $159.5 million in the third quarter 2013…

5 things to read during Contact Lens Health Week

November 19, 2014
The U.S. Centers for Disease Control and Prevention and the American Optometric Association have partnered to launch Contact Lens Health Week, an…

Ophthotec reports $39.6 million revenue in third quarter

November 19, 2014
Ophthotec reported $39.6 million in revenue in the third quarter, as well as a 9-month net loss of $62.3 million, according to a company press…
More Headlines »
morganatic-roan